QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:CME

CME Group (CME) Stock Forecast, Price & News

$185.30
+5.28 (+2.93%)
(As of 06/2/2023 ET)
Compare
Today's Range
$180.14
$185.68
50-Day Range
$176.67
$195.19
52-Week Range
$166.54
$212.09
Volume
1.58 million shs
Average Volume
1.70 million shs
Market Capitalization
$66.66 billion
P/E Ratio
23.55
Dividend Yield
2.37%
Price Target
$217.25

CME Group MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.58 Rating Score
Upside/​Downside
14.8% Upside
$212.73 Price Target
Short Interest
Healthy
1.15% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.26
Upright™ Environmental Score
News Sentiment
0.42mentions of CME Group in the last 14 days
Based on 9 Articles This Week
Insider Trading
Acquiring Shares
$2,409 Bought Last Quarter
Proj. Earnings Growth
1.49%
From $8.73 to $8.86 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.84 out of 5 stars

Finance Sector

198th out of 874 stocks

Security & Commodity Brokers, Dealers, Exchanges & Services Industry

3rd out of 9 stocks


CME stock logo

About CME Group (NASDAQ:CME) Stock

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Receive CME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.

CME Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Short Interest in CME Group Inc. (NASDAQ:CME) Drops By 5.7%
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Own A Piece Of The Exchanges By Buying CME Group
Insider Stock Buying Reaches US$8.9m On CME Group
See More Headlines

CME Price History

CME Company Calendar

Ex-Dividend for 3/27 Dividend
3/09/2023
Dividend Payable
3/27/2023
Last Earnings
4/26/2023
Today
6/02/2023
Ex-Dividend for 6/27 Dividend
6/08/2023
Dividend Payable
6/27/2023
Next Earnings (Estimated)
7/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Security & commodity brokers, dealers, exchanges & services
Sub-Industry
Specialized Finance
Sector
Finance
Current Symbol
NASDAQ:CME
CUSIP
12572Q10
Employees
3,460
Year Founded
1848

Price Target and Rating

Average Stock Price Forecast
$212.73
High Stock Price Forecast
$250.00
Low Stock Price Forecast
$161.00
Forecasted Upside/Downside
+20.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.58
Research Coverage
11 Analysts

Profitability

Net Income
$2.69 billion
Pretax Margin
72.95%

Debt

Sales & Book Value

Annual Sales
$5.02 billion
Cash Flow
$9.15 per share
Book Value
$76.13 per share

Miscellaneous

Free Float
358,639,000
Market Cap
$64.76 billion
Optionable
Optionable
Beta
0.41

Social Links


Key Executives

  • Terrence A. DuffyTerrence A. Duffy
    Executive Chairman & Chief Executive Officer
  • Julie HolzrichterJulie Holzrichter
    Chief Operating Officer & Senior Managing Director
  • Lynne Fitzpatrick
    Chief Financial Officer
  • Sunil CutinhoSunil Cutinho
    Chief Information Officer
  • Kendal VromanKendal Vroman
    Chief Transformation Officer













CME Stock - Frequently Asked Questions

Should I buy or sell CME Group stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CME shares.
View CME analyst ratings
or view top-rated stocks.

What is CME Group's stock price forecast for 2023?

11 analysts have issued 1-year price targets for CME Group's stock. Their CME share price forecasts range from $161.00 to $250.00. On average, they anticipate the company's stock price to reach $212.73 in the next twelve months. This suggests a possible upside of 14.9% from the stock's current price.
View analysts price targets for CME
or view top-rated stocks among Wall Street analysts.

How have CME shares performed in 2023?

CME Group's stock was trading at $168.16 at the beginning of the year. Since then, CME stock has increased by 10.1% and is now trading at $185.13.
View the best growth stocks for 2023 here
.

Are investors shorting CME Group?

CME Group saw a decrease in short interest in May. As of May 15th, there was short interest totaling 4,110,000 shares, a decrease of 5.7% from the April 30th total of 4,360,000 shares. Based on an average trading volume of 1,540,000 shares, the days-to-cover ratio is presently 2.7 days. Approximately 1.2% of the company's shares are short sold.
View CME Group's Short Interest
.

When is CME Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our CME earnings forecast
.

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) posted its earnings results on Wednesday, April, 26th. The financial services provider reported $2.42 EPS for the quarter, beating the consensus estimate of $2.36 by $0.06. The financial services provider earned $1.44 billion during the quarter, compared to analyst estimates of $1.42 billion. CME Group had a trailing twelve-month return on equity of 10.88% and a net margin of 55.99%. The business's revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.11 EPS.
Read the conference call transcript
.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group declared a quarterly dividend on Thursday, May 4th. Investors of record on Friday, June 9th will be given a dividend of $1.10 per share on Tuesday, June 27th. This represents a $4.40 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date of this dividend is Thursday, June 8th.
Read our dividend analysis for CME
.

Is CME Group a good dividend stock?

CME Group (NASDAQ:CME) pays an annual dividend of $4.40 per share and currently has a dividend yield of 2.46%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 55.91%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 49.66% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

What is Terry Duffy's approval rating as CME Group's CEO?

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

Who are CME Group's major shareholders?

CME Group's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (7.35%), State Street Corp (4.28%), Bank of New York Mellon Corp (2.14%), Geode Capital Management LLC (1.97%), Parnassus Investments LLC (1.43%) and Fiera Capital Corp (1.18%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends
.

How do I buy shares of CME Group?

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $185.13.

How much money does CME Group make?

CME Group (NASDAQ:CME) has a market capitalization of $66.59 billion and generates $5.02 billion in revenue each year. The financial services provider earns $2.69 billion in net income (profit) each year or $7.87 on an earnings per share basis.

How many employees does CME Group have?

The company employs 3,460 workers across the globe.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The official website for the company is www.cmegroup.com. The financial services provider can be reached via phone at (312) 930-1000, via email at info@cmegroup.com, or via fax at 312-466-4410.

This page (NASDAQ:CME) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -